340B Drug Pricing Program
AHA 340B Advocacy Alliance for January 7, 2025
AHA 340B Advocacy Alliance Bulletin for January 6, 2025.
AHA shares feedback in response to the Centers for Medicare & Medicaid Services’ information collection request (ICR) regarding the Medicare Transaction Facilitator (MTF) and the Medicare drug negotiation program.
Our Lady of the Lake Health, a part of the Franciscan Missionaries of Our Lady Health System, has been a leading provider of high-quality care in the Baton Rouge community for more than 100 years.
The Health Resources and Services Administration last week directed Sanofi to cease implementation of its 340B rebate proposal immediately and to inform HRSA of its plans no later than Dec. 20 in order to provide adequate notice to covered entities.
AHA 340B Advocacy Alliance Bulletin for December 16, 2024.
The net prices of five drugs included in a new study from the Institute for Clinical and Economic Review increased without clinical justification in 2023. These increases led to $815 million incremental added costs for U.S. payers.
AHA urges 340B members to complete a brief survey to help the association understand how a 340B rebate model — such as the one Johnson & Johnson sought to implement this year — would impact 340B member hospitals.
As the largest rural hospital in Eastern Kentucky, UK St. Claire is part of an integrated health system serving as the primary provider across 11 counties in the region and caring for 170,000 patients annually.
340B Advocacy Alliance Bulletin for December 3, 2024.